Coordination Compounds As Multi-Delivery Systems for Osteoporosis
authors Barbosa, JS; Pinto, M; Barreiro, S; Fernandes, C; Mendes, RF; Lavrador, P; Gaspar, VM; Mano, JF; Borges, F; Remiao, F; Braga, SS; Paz, FAA
nationality International
journal ACS APPLIED MATERIALS & INTERFACES
author keywords osteoporosis; bisphosphonates; coordination compounds; controlled release; toxicological safety
keywords BONE-MINERAL DENSITY; CALCIUM SUPPLEMENTATION; STRONTIUM RANELATE; BISPHOSPHONATE; NANOPARTICLES; EPIDEMIOLOGY; PREVENTION; EFFICACY
abstract Osteoporosis therapies leveraging bisphosphonates and mineral components (e.g., magnesium, calcium, and strontium) have been raising attention because of their potential for managing this ever-growing disease. The administration of multicomponent therapeutics (combined therapy) in elderly patients is complex and suffers from low patient adherence. Herein, we report an all-in-one combination of four antiosteoporotic components into a new family of coordination complexes: [M-2(H(4)alen)(4)(H2O)(2)]center dot 1.5H(2)O [where M2+ = Mg2+ (1), (Mg0.535Ca0.465)(2+) (2) and (Mg0.505Ca0.450Sr0.045)(2+) (3)]. These solid-state complexes were prepared, for the first time, through microwave-assisted synthesis. It is demonstrated that the compounds are capable of releasing their antiosteoporotic components, both in conditions that mimic the path along the gastrointestinal tract and in long periods under physiological conditions (pH similar to 7.4). More importantly, when administered in low concentrations, the compounds did not elicit a cytotoxic effect toward liver, kidney, and osteoblast-like cell lines. Besides, it is important to highlight the unique coordination complex with four bone therapeutic components, [(Mg0.505Ca0.450Sr0.045)(2)(H(4)alen)(4)(H2O)(2)]center dot 1.5H(2)O (3), which significantly promoted osteoblast metabolic activity up to ca. 1.4-fold versus the control group. These findings bring this type of compounds one-step closer to be considered as an all-in-one and more effective treatment for managing chronic bone diseases, prompting further research on their therapeutic properties.
publisher AMER CHEMICAL SOC
issn 1944-8244
isbn 1944-8252
year published 2021
volume 13
issue 30
beginning page 35469
ending page 35483
digital object identifier (doi) 10.1021/acsami.1c09121
web of science category 15
subject category Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
unique article identifier WOS:000683741400020
  ciceco authors
  impact metrics
journal analysis (jcr 2019):
journal impact factor 8.758
5 year journal impact factor 8.901
category normalized journal impact factor percentile 86.33
dimensions (citation analysis):
altmetrics (social interaction):



 


Sponsors

1suponsers_list_ciceco.jpg